Nexalin Technology (NASDAQ: NXL) reported Q3 2023 earnings per share (EPS) of -$0.31, up 933.33% year over year. Total Nexalin Technology earnings for the quarter were -$2.30 million. In the same quarter last year, Nexalin Technology's earnings per share (EPS) was -$0.03.
As of Q1 2024, Nexalin Technology's earnings has grown year over year. Nexalin Technology's earnings in the past year totalled -$4.60 million.
What was NXL's revenue last quarter?
Nexalin Technology (NASDAQ: NXL) reported Q3 2023 revenue of $24.11 thousand up 95.58% year over year. In the same quarter last year, Nexalin Technology's revenue was $545.32 thousand.
What was NXL's revenue growth in the past year?
As of Q1 2024, Nexalin Technology's revenue has grown -90.16% year over year. This is 99.25 percentage points lower than the US Medical Devices industry revenue growth rate of 9.1%. Nexalin Technology's revenue in the past year totalled $128.64 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.